Cargando…

Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is one of the most common and increasing liver diseases worldwide. NAFLD is a term that involves a variety of conditions such as fatty liver, steatohepatitis, or fibrosis. Gut microbiota and its products have been extensively studied because of a close relati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Eunju, Jeong, Jin-Ju, Won, Sung-Min, Sharma, Satya Priya, Gebru, Yoseph Asmelash, Ganesan, Raja, Gupta, Haripriya, Suk, Ki Tae, Kim, Dong Joon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534099/ https://www.ncbi.nlm.nih.gov/pubmed/34685614 http://dx.doi.org/10.3390/cells10102634

Ejemplares similares

The Gut Microbiota-Derived Immune Response in Chronic Liver Disease
por: Won, Sung-Min, et al.
Publicado: (2021)

T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Gebru, Yoseph Asmelash, et al.
Publicado: (2021)

Pathophysiological Roles of Mucosal-Associated Invariant T Cells in the Context of Gut Microbiota-Liver Axis
por: Gebru, Yoseph Asmelash, et al.
Publicado: (2021)

Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease
por: Jeong, Min Kyo, et al.
Publicado: (2022)

Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
por: Gupta, Haripriya, et al.
Publicado: (2022)

The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study
por: Oh, Ki-Kwang, et al.
Publicado: (2023)

Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
por: Sharma, Satya Priya, et al.
Publicado: (2021)

Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications
por: Raja, Ganesan, et al.
Publicado: (2021)

The juxtaposition of Ilex cornuta fruit and gut microbiota against alcoholic liver disease based on the integrated pharmacology via metabolomics
por: Oh, Ki‐Kwang, et al.
Publicado: (2023)

Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver
por: Gupta, Haripriya, et al.
Publicado: (2021)

Nutritional Status and Diet Style Affect Cognitive Function in Alcoholic Liver Disease
por: Choi, Ye Rin, et al.
Publicado: (2021)

The Lactobacillus as a Probiotic: Focusing on Liver Diseases
por: Jeong, Jin-Ju, et al.
Publicado: (2022)

The Link between Gut Microbiota and Hepatic Encephalopathy
por: Won, Sung-Min, et al.
Publicado: (2022)

Role of Gut Microbiota in Hepatocarcinogenesis
por: Gupta, Haripriya, et al.
Publicado: (2019)

Diet-Regulating Microbiota and Host Immune System in Liver Disease
por: Eom, Jung A, et al.
Publicado: (2021)

The identification of metabolites from gut microbiota in NAFLD via network pharmacology
por: Oh, Ki-Kwang, et al.
Publicado: (2023)

Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease
por: Oh, Ki-Kwang, et al.
Publicado: (2022)

Gut Microbiota and Risk of Persistent Nonalcoholic Fatty Liver Diseases
por: Kim, Han-Na, et al.
Publicado: (2019)

Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology Study
por: Oh, Ki-Kwang, et al.
Publicado: (2022)

Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function
por: Hong, Ji Taek, et al.
Publicado: (2021)

Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
por: Boursier, Jerome, et al.
Publicado: (2015)

Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis
por: Yoon, Sang Jun, et al.
Publicado: (2023)

Isolation and Characterization of Probiotic LAB from Kimchi and Spontaneously Fermented Teff (Eragrostis tef (Zucc.) Trotter) Batter: Their Effects on Phenolic Content of Teff during Fermentation
por: Gebru, Yoseph Asmelash, et al.
Publicado: (2020)

Recent Trends of Microbiota-Based Microbial Metabolites Metabolism in Liver Disease
por: Ganesan, Raja, et al.
Publicado: (2022)

Gut microbiota profile in patients with nonalcoholic fatty liver disease and presumed nonalcoholic steatohepatitis
por: Mohammadi, Zahra, et al.
Publicado: (2022)

Retraction: Nonalcoholic fatty liver disease, diet and gut microbiota
por: Finelli, Carmine, et al.
Publicado: (2017)

Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease
por: Zhao, Yuzhen, et al.
Publicado: (2019)

Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis
por: Gupta, Haripriya, et al.
Publicado: (2022)

Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
por: Park, Ji Sook, et al.
Publicado: (2013)

The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation
por: van Best, Niels, et al.
Publicado: (2015)

Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy
por: Ma, Junli, et al.
Publicado: (2017)

Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease
por: Bibbò, Stefano, et al.
Publicado: (2018)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021)

Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics
por: He, Xuyun, et al.
Publicado: (2016)

Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
por: Li, Xia, et al.
Publicado: (2018)

Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2019)

The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease
por: Park, Grace, et al.
Publicado: (2021)

The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease
por: Gu, Congwei, et al.
Publicado: (2022)

Characterization of gut dominant microbiota in obese patients with nonalcoholic fatty liver disease
por: Jin, Li-ting, et al.
Publicado: (2023)

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
por: Park, Ji-Won, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pinsv75g69t7b3rt2c92ssaks6